Key Insights

Highlights

Success Rate

68% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

27.3%

6 terminated out of 22 trials

Success Rate

68.4%

-18.1% vs benchmark

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

69%

9 of 13 completed with results

Key Signals

9 with results68% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (3)
P 1 (8)
P 2 (6)
P 3 (1)

Trial Status

Completed13
Terminated6
Unknown3

Trial Success Rate

68.4%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT00619879Completed

Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies

NCT02475707Phase 1CompletedPrimary

Administration of Donor MultiTAA-Specific T Cells for ALL

NCT01186328Phase 1Terminated

EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)

NCT01041508Phase 1CompletedPrimary

Clofarabine and Low Dose Total Body Irradiation as a Preparative Regimen for Stem Cell Transplant in Leukemia.

NCT00475280Phase 2CompletedPrimary

"Geriatric Assessment Adapted" Therapy for Ph- ALL Elderly Patients

NCT03627208CompletedPrimary

Optimal Methods of Disease Detection in Children and Young Adults With Acute Lymphoblastic Leukemia in the Pediatric Oncology Branch

NCT01158885Phase 2Terminated

Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia

NCT01045382Phase 2Terminated

MSC and HSC Coinfusion in Mismatched Minitransplants

NCT00859586Not ApplicableCompleted

Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation

NCT00539656Phase 1Terminated

Transplantation of Umbilical Cord Blood Following Chemotherapy for Blood Cancers

NCT00179764Not ApplicableCompleted

Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])

NCT02264873Phase 1CompletedPrimary

Phase I, Dose Escalation Study of Decitabine

NCT03235973Phase 1Unknown

Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelodysplastic Syndromes

NCT03331211UnknownPrimary

Observation of the Effect of Chemotherapy Combined With Tyrosinase Inhibitor on the Reactivation of CMV and EBV in Patients With Acute Lymphoblastic Leukemia

NCT00241358Phase 1Completed

Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies

NCT00186901Phase 3CompletedPrimary

A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors

NCT01976442Completed

Use of Saline-Washed Platelet and Red Cell Transfusions in Adult Acute Leukemia

NCT02888990Phase 2CompletedPrimary

Dasatinib and Low Intensity Chemotherapy for Ph+ Acute Lymphoblastic Leukemia

NCT01100658Not ApplicableTerminated

Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors

NCT00916045Phase 2Terminated

Pilot Study of Unrelated Cord Blood Transplantation

Scroll to load more

Research Network

Activity Timeline